Literature DB >> 8477781

Cultured cell lines from human teratomas: windows into tumour growth and differentiation and early human development.

S Roach1, S Cooper, W Bennett, M F Pera.   

Abstract

Cultured cell lines from human teratomas provide models to study molecules which might regulate tumour growth or normal embryonic development. Here, we describe efforts to delineate the role of transcription factors, extracellular matrix, and growth factors in controlling growth and differentiation of human embryonal carcinoma and yolk sac tumour.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477781     DOI: 10.1159/000474574

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

2.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  Stem cells: potential therapeutics for periodontal regeneration.

Authors:  Karina Gonzales Silvério; Bruno Braga Benatti; Márcio Zaffalon Casati; Enílson Antônio Sallum; Francisco Humberto Nociti
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

4.  Assessment of pluripotency and multilineage differentiation potential of NTERA-2 cells as a model for studying human embryonic stem cells.

Authors:  Rajarshi Pal; Geeta Ravindran
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

5.  Isolation of a primate embryonic stem cell line.

Authors:  J A Thomson; J Kalishman; T G Golos; M Durning; C P Harris; R A Becker; J P Hearn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 6.  Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy.

Authors:  C Bokemeyer; M A Kuczyk; H Köhne; H Einsele; B Kynast; H J Schmoll
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.